Tianyi Jiang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
LAMC2 promotes gallbladder carcinoma metastasis through the TGF-β pathway.
Journal: Cancer cell international
Published: May 27, 2025
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Journal: Frontiers in immunology
Published: February 15, 2023
URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.
Journal: Nature communications
Published: December 26, 2022
A translational strategy employing physiologically based modelling to predict the pharmacological active dose of RO7119929, an oral prodrug of a targeted cancer immunotherapy TLR7 agonist.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: August 25, 2022
Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases.
Journal: Genes & diseases
Published: July 26, 2022
Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma.
Journal: Cells
Published: February 11, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma.
Journal: Cell death & disease
Published: January 16, 2022
Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography-Mass Spectrometry-Based Metabolomics.
Journal: Cancers
Published: November 24, 2021
RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding.
RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding.
Journal: Cell death & disease
Published: June 16, 2021
Prognosis prediction of hepatocellular carcinoma after surgical resection based on serum metabolic profiling from gas chromatography-mass spectrometry.
Journal: Analytical and bioanalytical chemistry
Published: January 05, 2021
Liquid Chromatography-Mass Spectrometry-Based Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection.
Journal: Journal of proteome research
Published: July 04, 2020
Last Updated: 09/26/2026